MeSH D009461 - neurologic manifestations
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D012816:Signs and symptoms
0 Companies
0 Drugs
Success rate
D009461:
Neurologic manifestations
D000071699:Bilateral vestibulopathy
0 Companies
0 Drugs
Success rate
D000082643:Cerebral cortical thinning
0 Companies
0 Drugs
Success rate
D001750:Neurogenic urinary bladder
D003655:Decerebrate state
0 Companies
0 Drugs
Success rate
D008580:Meningism
0 Companies
0 Drugs
Success rate
D010243:Paralysis
0 Companies
0 Drugs
Success rate
D010291:Paresis
0 Companies
0 Drugs
Success rate
D011681:Pupil disorders
0 Companies
0 Drugs
Success rate
D012021:Abnormal reflex
0 Companies
0 Drugs
Success rate
D012640:Seizures
D012678:Sensation disorders
0 Companies
0 Drugs
Success rate
D014717:Vertigo
D014832:Voice disorders
0 Companies
0 Drugs
Success rate
D020078:Neurogenic inflammation
0 Companies
0 Drugs
Success rate
D020233:Neurologic gait disorders
D020820:Dyskinesias
D020879:Neuromuscular manifestations
0 Companies
0 Drugs
Success rate
D055955:Susac syndrome
0 Companies
0 Drugs
Success rate
D065634:Cerebrospinal fluid leak
0 Companies
0 Drugs
Success rate
D010146:Pain
D011602:Psychophysiologic disorders
D012893:Sleep wake disorders
D054971:Orthostatic intolerance
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
100%1/1
Phase 2
17%1/6
Phase 3
50%1/2
Approved: 1Overall Success rate: 8%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use